Shuangcheng Pharmaceutical announced that the company previously disclosed that LI JIANMING, Yuan Jianlin, Yao Zhong, Ai Yixiang, and Wang Rui plan to reduce their holdings by no more than 442,500 shares in total from July 22, 2026 to October 21, 2026, accounting for 0.10% of the total share capital; as of October 21, 2026, the holdings reduction plan period will expire. LI JIANMING, YUAN JIANLIN, AI YIXIANG, and WANG Rui reduced their holdings by 240,000 shares, 81,000 shares, 18,000 shares, and 15,525 shares respectively, accounting for 0.06%, 0.02%, 0.00%, and 0.00% of the total share capital.
Zhitongcaijing · 1d ago
Share
Listen to the news
Shuangcheng Pharmaceutical announced that the company previously disclosed that LI JIANMING, Yuan Jianlin, Yao Zhong, Ai Yixiang, and Wang Rui plan to reduce their holdings by no more than 442,500 shares in total from July 22, 2026 to October 21, 2026, accounting for 0.10% of the total share capital; as of October 21, 2026, the holdings reduction plan period will expire. LI JIANMING, YUAN JIANLIN, AI YIXIANG, and WANG Rui reduced their holdings by 240,000 shares, 81,000 shares, 18,000 shares, and 15,525 shares respectively, accounting for 0.06%, 0.02%, 0.00%, and 0.00% of the total share capital.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending